Tevogen (TVGN) News
NASDAQ: TVGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.78-0.28 (-3.97%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
TVGN news summary
We found 2 recent headlines mentioning Tevogen (TVGN): 2 in the past week and 2 in the past 30 days, most often from GlobeNewswire. For price context, TVGN is down 3.97% at $6.78. The most recent story, "UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC", was published by GlobeNewswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Tevogen headlines
- UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLCWARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN ), an integrated healthcare enterprise combining biopharma, artificial intelligence, and…GlobeNewswire
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLCWARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN ), an integrated healthcare enterprise combining biopharma, artificial intelligence, and…GlobeNewswire